Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
US8124078B2 · kind B2 · utility
0Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2009 |
| Grant date | Feb 28, 2012 |
| Priority date | — |
| Expiry date | Jan 22, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/732
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcγ receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.